[Federal Register Volume 60, Number 240 (Thursday, December 14, 1995)]
[Notices]
[Pages 64165-64166]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-30446]
=======================================================================
-----------------------------------------------------------------------
[[Page 64166]]
PRESIDENTIAL ADVISORY COMMITTEE ON GULF WAR VETERANS' ILLNESSES
Meeting
AGENCY: Presidential Advisory Committee on Gulf War Veterans'
Illnesses.
ACTION: Notice of open meeting.
-----------------------------------------------------------------------
SUMMARY: This notice is hereby given to announce an open meeting of a
panel of the Presidential Advisory Committee on Gulf War Veterans'
Illnesses. The panel will discuss decisionmaking related to the use of
investigational drugs and vaccines in the Gulf War and will receive
comment from members of the public. Dr. Arthur L. Caplan will chair
this panel meeting.
DATES: January 12, 1996, 8:30 a.m.-4:00 p.m.
PLACE: Westin Crown Center, One Pershing Road, Kansas City, MO 64108.
SUPPLEMENTARY INFORMATION: The President established the Presidential
Advisory Committee on Gulf War Veterans' Illnesses by Executive Order
12961, May 26, 1995. The purpose of this committee is to review and
provide recommendations on the full range of government activities
associated with Gulf War veterans' illnesses. The committee reports to
the President through the Secretary of Defense, the Secretary of Health
and Human Services, and the Secretary of Veterans Affairs. The
committee members have expertise relevant to the functions of the
committee and are appointed by the President from non-Federal sectors.
Tentative Agenda
Friday, January 12, 1996
8:30 a.m. Call to order and opening remarks
8:40 a.m. Public comment
10:00 a.m. Break
10:15 a.m. Public comment (cont.)
11:15 a.m. Briefings and discussion on decisionmaking processes
12:15 p.m. Lunch
1:30 p.m. Briefings and discussion on waiver informed consent
2:30 p.m. Break
2:45 p.m. Briefings and discussion on current policy and
implications for the future
3:45 p.m. Strategies and next steps
4:00 p.m. Meeting adjourned
A final agenda will be available at the meeting.
Public Participation
The meeting is open to the public. Members of the public who wish
to make oral statements should contact the Advisory Committee at the
address or telephone number listed below at least five business days
prior to the meeting. Reasonable provisions will be made to include on
the agenda presentations from individuals who have not yet had an
opportunity to address the Advisory Committee. The panel chair is
empowered to conduct the meeting in a fashion that will facilitate the
orderly conduct of business. People who wish to file written statements
with the Advisory Committee may do so at any time.
FOR FURTHER INFORMATION CONTACT: Michael E. Kowalok, Presidential
Advisory Committee on Gulf War Veterans' Illnesses, 1411 K Street, NW.,
suite 1000, Washington, DC 20005, Telephone: (202) 761-0066, Fax: (202)
761-0310.
Dated: December 8, 1995.
C.A. Bock,
Federal Register Liaison Officer, Presidential Advisory Committee on
Gulf War Veterans' Illnesses.
[FR Doc. 95-30446 Filed 12-13-95; 8:45 am]
BILLING CODE 3610-76-M
